Profound Medical (PROF) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Profound Medical (PROF) has outperformed Neuronetics (STIM) over the past year, losing 12.1% versus a loss of 25.4%. Over five years, STIM leads with a -55.3% price change compared with -62.2% for PROF. Profound Medical is the larger company by market cap ($207.5 million vs $165.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PROF | STIM |
|---|---|---|
| Share price | $5.68 | $2.17 |
| Market cap | $207.55M | $165.35M |
| 1-day change | -6.58% | -1.81% |
| YTD return | -27.83% | +57.25% |
| 1-year return | -12.07% | -25.43% |
| 5-year return | -62.16% | -55.35% |
| EPS (TTM) | $-0.99 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.95 | $3.44 |
| 52-week low | $4.80 | $0.80 |
| Distance from 52-week high | -36.54% | -36.92% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +96.13% | +164.98% |
| Average volume | 121.06K | 2.10M |
| Shares outstanding | 36.54M | 76.20M |
| Employees | 162 | 658 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PROF has outperformed STIM by 13.4 percentage points over the past year.
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Healthcare · Medical Devices · 162 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Healthcare · Medical Devices · 658 employees
PROF vs STIM FAQ
Which is bigger, Profound Medical or Neuronetics?
Profound Medical (PROF) is larger, with a market capitalization of $207.55M compared with $165.35M for Neuronetics (STIM).
Which stock has performed better over the past year, PROF or STIM?
PROF returned -12.07% over the past 12 months, compared with -25.43% for STIM (price return, excluding dividends). Past performance does not predict future results.
Are Profound Medical and Neuronetics in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.